The Recall Desk
ModerateFDA (Drugs)·D-1159-2022·Announced 2022-06-22

Artri King Reforzado con Ortiga Omega 3 Tablets Recalled as Unapproved Drug

Walmart Inc is recalling Artri King Reforzado con Ortiga Omega 3 Tablets nationwide because the product was marketed as a drug without FDA approval. All lots are affected.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA classified this as a Class II recall. No illnesses or injuries have been reported. The hazard is regulatory non-compliance—the product was marketed as a drug without proper FDA approval.

Plain-English summary

Walmart Inc is recalling all lots of Artri King Reforzado con Ortiga Omega 3 Tablets (ORIGINAL) nationwide. The tablets are available in two configurations: 100-count bottles (UPC 7 501031 111190 or UPC 6 09002 40885) and 2-pack boxes of 100-count bottles (UPC 3 72426 01434). A total of 1,308 bottles are affected by this recall.

The recall was issued because the product was found to be marketed as an unapproved drug based on its labeling claims. The tablets lack required FDA approval (New Drug Application or Abbreviated New Drug Application) to be legally marketed as a drug.

Consumers who have purchased this product should not use it. If you have this product, contact Walmart for information on how to return or dispose of it safely.

The recalled product

Product
Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, a) 100-count bottles labeled with UPC 7 501031 111190 and UPC 6 09002 40885, and b) 2 pack of 100-count bottles per carton UPC 3 72426 01434
Manufacturer
Walmart Inc
Category
Drug
Hazard
  • unapproved-drug

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All product lots.

Distribution

Distributed nationwide across the United States.

Related recalls

Same category